Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
1997-4-4
|
pubmed:abstractText |
40 infantile autistic patients were studied. They ranged from 6 years to 15 years of age at entry. 22 were cases of classical infantile autism; whereas 18 lacked one or more clinical defects associated with infantile autism ("pseudo-autism"). Of the 22 with classic autism, 21 responded to transfer factor (TF) treatment by gaining at least 2 points in symptoms severity score average (SSSA); and 10 became normal in that they were main-streamed in school and clinical characteristics were fully normalized. Of the 18 remaining, 4 responded to TF, some to other therapies. After cessation of TF therapy, 5 in the autistic group and 3 of the pseudo-autistic group regressed, but they did not drop as low as baseline levels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0921-299X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8993773-Adolescent,
pubmed-meshheading:8993773-Antibodies,
pubmed-meshheading:8993773-Autistic Disorder,
pubmed-meshheading:8993773-Cell Extracts,
pubmed-meshheading:8993773-Child,
pubmed-meshheading:8993773-Dialysis,
pubmed-meshheading:8993773-Follow-Up Studies,
pubmed-meshheading:8993773-Humans,
pubmed-meshheading:8993773-Lymphocytes,
pubmed-meshheading:8993773-Myelin Basic Proteins,
pubmed-meshheading:8993773-Pilot Projects,
pubmed-meshheading:8993773-Transfer Factor
|
pubmed:year |
1996
|
pubmed:articleTitle |
Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study.
|
pubmed:affiliation |
Neurolmmuno Therapeutics Research Foundation Spartanburg, S.C., USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|